E C Baselli|R E Greenberg - JoVE Visualize

Showing results (31-40 of 38) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 38 results.

Urology|April 18, 2001

Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancerD Cvetkovic, B Movsas, A P Dicker, et al.

American Journal of Clinical Oncology|October 5, 2001

Hypoxia in human prostate carcinoma: an Eppendorf PO2 studyB Movsas, J D Chapman, A L Hanlon, et al.

Urology|January 14, 1999

Hypoxic regions exist in human prostate carcinomaB Movsas, J D Chapman, E M Horwitz, et al.

Cancer|November 7, 2000

Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) studyB Movsas, J D Chapman, R E Greenberg, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 28, 1995

Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probesC A Thrash-Bingham, R E Greenberg, S Howard, et al.

BJU International|May 15, 2004

Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancerR G Uzzo, J G Brown, E M Horwitz, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1995

Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancerM R Goldberg, D C Heimbrook, P Russo, et al.

Urology|March 1, 1997

Initial report on intravesical administration of N-trifluoroacetyladriamycin-14-valerate (AD 32) to patients with refractory superficial transitional cell carcinoma of the urinary bladderR E Greenberg, R R Bahnson, D Wood, et al.

Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 38 results.

Urology|April 18, 2001

Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancerD Cvetkovic, B Movsas, A P Dicker, et al.

American Journal of Clinical Oncology|October 5, 2001

Hypoxia in human prostate carcinoma: an Eppendorf PO2 studyB Movsas, J D Chapman, A L Hanlon, et al.

Urology|January 14, 1999

Hypoxic regions exist in human prostate carcinomaB Movsas, J D Chapman, E M Horwitz, et al.

Cancer|November 7, 2000

Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) studyB Movsas, J D Chapman, R E Greenberg, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 28, 1995

Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probesC A Thrash-Bingham, R E Greenberg, S Howard, et al.

BJU International|May 15, 2004

Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancerR G Uzzo, J G Brown, E M Horwitz, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1995

Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancerM R Goldberg, D C Heimbrook, P Russo, et al.

Urology|March 1, 1997

Initial report on intravesical administration of N-trifluoroacetyladriamycin-14-valerate (AD 32) to patients with refractory superficial transitional cell carcinoma of the urinary bladderR E Greenberg, R R Bahnson, D Wood, et al.

Pageof 4